Journal article 510 views 81 downloads
Sepsis target validation for repurposing and combining complement and immune checkpoint inhibition therapeutics
Patrícia R.S. Rodrigues,
Noemi Picco 
,
B Paul Morgan,
Peter Ghazal
,
B Paul Morgan,
Peter Ghazal
Expert Opinion on Drug Discovery, Volume: 16, Issue: 5, Pages: 537 - 551
Swansea University Author:
Noemi Picco
-
PDF | Version of Record
© 2020 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License
Download (4.39MB)
DOI (Published version): 10.1080/17460441.2021.1851186
Abstract
Sepsis target validation for repurposing and combining complement and immune checkpoint inhibition therapeutics
| Published in: | Expert Opinion on Drug Discovery |
|---|---|
| ISSN: | 1746-0441 1746-045X |
| Published: |
Informa UK Limited
2021
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa55698 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Keywords: |
Anaphylatoxins; c5a; complement; immune checkpoint; pattern recognition molecules (PRMs); sepsis; t-cell dysfunction; biologic-therapy |
|---|---|
| College: |
Faculty of Science and Engineering |
| Issue: |
5 |
| Start Page: |
537 |
| End Page: |
551 |